To more precisely illustrate the process of anti-fungal immunity mediated by CLRs in bladder cancer, we need to further discuss the immune interactions among the mycobiome, CLRs, and immune cells from an anatomical perspective. Here, LARS1 is linked to urinary bladder carcinoma.